カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の体外受精市場2023-2030：機器別（使い捨て機器、培養液）、処置種類別（新鮮ノンドナー、凍結ノンドナー）、エンドユーザー別

【英語タイトル】In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By End-use, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV147）・商品コード：GRV23NOV147
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥892,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,042,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,342,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

体外受精市場の成長と動向
Grand View Research社の最新レポートによると、体外受精の世界市場規模は2030年までに374億米ドルに達する見込みです。2023年から2030年までの年平均成長率は5.72%と予測されています。市場の成長は、市場プレイヤーの継続的な努力、ライフスタイルの変化による不妊症の発生率の増加、償還政策を改善するための政府の取り組みによるものです。不妊治療のための顕微授精などの不妊治療の拡大は、市場成長にプラスの影響を与えると予想されます。

さらに、体外受精（IVF）の際に遺伝性疾患の移行を予防できるゲノム検査施設が利用できるようになったことも、IVF市場を牽引すると予想されます。体外受精治療件数の増加に伴い、保険会社は体外受精治療に対する保険金を支給しています。例えば、2023年5月、パシフィック・ブルークロスは、不妊治療薬、不妊治療、養子縁組の補償を含む家族計画給付を組み込んだ、ヘルス＆デンタルプランである拡張パーソナル・ヘルス保険を導入しました。この機能強化により、パシフィック・ブルー・クロスは、カナダで初めて、そして唯一、個人向けヘルス＆デンタル・プランの一部として家族計画給付を提供する保険会社となりました。これにより競争力のある価格設定となり、体外受精の治療費も抑えられました。体外受精は、治療の自動化と標準化によって市場を牽引し、成功裏に実施された技術です。

合計特殊出生率（TFR）の低下は、社会における行動の変化などの要因に起因します。農村社会から都市社会へのシフト、初回妊娠年齢の上昇、結婚の先送り、雇用の増加、婚姻率の低下などです。2020年3月、米国生殖医学会とカナダ不妊・アンドロロジー学会はCOVID-19により、米国とカナダでの対面不妊治療を一時停止しました。しかし、COVID-19の規制緩和により多くの国で治療が再開されています。2022年1月にObstetrics & Gynecology誌が発表した研究結果では、COVID-19ワクチンは体外受精の成績に悪影響を与えないことが報告されました。このことは、ワクチン接種対象者の体外受精の利用を促進する上で重要であることが証明される見込みです。

体外受精市場レポートハイライト

- 2022年の体外受精市場は、凍結ノンドナー法が他の方法に比べて体外受精サイクル数が増加していることから、凍結ノンドナー法が市場を独占しました。

- 費用対効果、専門医の確保、卵子・精子バンクとの良好な関係、院内感染の可能性の最小化または皆無に加え、ART治療に対する需要の増加により、不妊治療クリニックの最終用途分野が2022年の市場を支配しました。

- 培養液の効率を向上させるための研究活動の増加、卵子・精子凍結のための政府助成金や従業員に対する組織的支援の増加により、培養液機器分野が2022年に最大のシェアを占めました。

- クリニックによるタイムラプス顕微鏡などの先端技術の採用の増加、手頃な価格の治療の利用可能性、医療基準の遵守により、欧州が2022年に最大の市場シェアを維持しました。

- アジア太平洋地域は、不妊治療の需要が高く、体外受精を支援する政策やイニシアティブが実施されているため、体外受精の需要が増加すると予想されます。日本では、資格のあるカップルは、1サイクルにつき1,920米ドルで最大3サイクルの自己資金を申請することができます。

- アジア太平洋地域の発展途上国では、不妊治療の普及に向けた法改正が進められています。例えば、2020年2月、インド政府は、体外受精、人工授精、代理出産を含む生殖補助医療サービスを提供するクリニックを規制する法案を承認しました。

- 2021年6月、フランスの下院は、独身女性とレズビアン・カップルに生殖補助医療へのアクセスを認める法律を正式に可決しました。この画期的な法律は、これらの個人やカップルが体外受精を含む不妊治療を無料で受けられるようにする、重要なマイルストーンとなります。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の体外受精市場：処置種類別分析
第5章 世界の体外受精市場：エンドユーザー別分析
第6章 世界の体外受精市場：機器別分析
第7章 地域別概要
第8章 競合分析

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Procedure Type
1.1.2. End-Use
1.1.3. Instrument
1.1.4. Region
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.3.1. Information procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.3.6. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.5.1. Volume Price Analysis
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Research Objectives
1.8.1. Objective – 1
1.8.2. Objective – 2
1.8.3. Objective – 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Procedure Type
2.2.2. End-Use
2.2.3. Instrument
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Segmentation
3.3. Penetration & Growth Prospect Mapping
3.4. Clinical Trials
3.5. User Perspective Analysis
3.5.1. Consumer Behavior Analysis
3.5.2. Market Influencer Analysis
3.6. Market Dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.7. Industry Analysis Tools
3.7.1. Porter’s Five Forces Analysis
3.7.2. PESTLE Analysis
3.7.3. Qualitative Analysis: Impact of COVID-19 on IVF Market
Chapter 4. In Vitro Fertilization Market: Procedure Type Analysis
4.1. In Vitro Fertilization by Procedure Type Market Share Analysis, 2022 & 2030
4.2. Segment Dashboard
4.3. Global In Vitro Fertilization Procedures Market, by Type, 2018 – 2030
4.4. Market Size and Forecasts and Trend Analysis, 2018 – 2030 for the Procedure Type
4.4.1. Fresh Nondonor
4.4.1.1. Fresh nondonor market, 2018 – 2030 (USD Million)
4.4.2. Frozen Nondonor
4.4.2.1. Frozen nondonor market, 2018 – 2030 (USD Million)
4.4.3. Fresh Donor
4.4.3.1. Fresh donor market, 2018 – 2030 (USD Million)
4.4.4. Frozen Donor
4.4.4.1. Frozen donor market, 2018 – 2030 (USD Million)
Chapter 5. In Vitro Fertilization Market: End-use Analysis
5.1. In Vitro Fertilization End-use Market Share Analysis, 2022 & 2030
5.2. Segment Dashboard
5.3. Market Size and Forecasts and Trend Analysis, 2018 – 2030 for the following End-Use
5.3.1. Fertility Clinics
5.3.1.1. Fertility clinics market, 2018 – 2030 (USD Million)
5.3.2. Hospitals & Other Settings
5.3.2.1. Hospitals & other settings market, 2018 – 2030 (USD Million)
Chapter 6. In Vitro Fertilization Market: Instrument Analysis
6.1. In Vitro Fertilization (IVF) Market Share Analysis, 2022 & 2030
6.2. Segment Dashboard
6.3. Global IVF Market, by Instrument, 2022 to 2030
6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Instrument
6.4.1. Culture Media
6.4.1.1. Culture media market, 2018 – 2030 (USD Million)
6.4.2. Disposable Devices
6.4.2.1. Disposable devices market, 2018 – 2030 (USD Million)
6.4.3. Capital Equipment
6.4.3.1. Capital equipment market, 2018 – 2030 (USD Million)
Chapter 7. Regional Outlook
7.1. IVF Market by Region: Key Marketplace Takeaway
7.2. List of Few Fertility Clinics
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. MEA
7.3. North America
7.3.1. North America IVF market, 2018 – 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. U.S. estimated fertility rate, 2018 – 2030 (%)
7.3.2.2. Regulatory framework
7.3.2.3. Reimbursement scenario
7.3.2.4. U.S. IVF market, 2018 – 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Canada estimated fertility rate, 2018 – 2030 (%)
7.3.3.2. Regulatory framework
7.3.3.3. Reimbursement scenario
7.3.3.4. Canada IVF market, 2018 – 2030 (USD Million)
7.4. Europe
7.4.1. Europe IVF market, 2018 – 2030 (USD Million)
7.4.2. France
7.4.2.1. France estimated fertility rate, 2018 – 2030 (%)
7.4.2.2. Regulatory framework
7.4.2.3. Reimbursement scenario
7.4.2.4. France IVF market, 2018 – 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Germany estimated fertility rate, 2018 – 2030 (%)
7.4.3.2. Regulatory framework
7.4.3.3. Reimbursement Scenario
7.4.3.4. Germany IVF market, 2018 – 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Italy estimated fertility rate, 2018 – 2030 (%)
7.4.4.2. Regulatory framework
7.4.4.3. Reimbursement scenario
7.4.4.4. Italy IVF market, 2018 – 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Spain estimated fertility rate, 2018 – 2030 (%)
7.4.5.2. Regulatory framework
7.4.5.3. Reimbursement scenario
7.4.5.4. Spain IVF market, 2018 – 2030 (USD Million)
7.4.6. UK
7.4.6.1. UK estimated fertility rate, 2018 – 2030 (%)
7.4.6.2. Regulatory framework
7.4.6.3. Reimbursement scenario
7.4.6.4. UK IVF market, 2018 – 2030 (USD Million)
7.4.7. Belgium
7.4.7.1. Belgium estimated fertility rate, 2018 – 2030 (%)
7.4.7.2. Regulatory framework
7.4.7.3. Reimbursement scenario
7.4.7.4. Belgium IVF market, 2018 – 2030 (USD Million)
7.4.8. The Netherlands
7.4.8.1. The Netherlands estimated fertility rate, 2018 – 2030 (%)
7.4.8.2. Regulatory framework
7.4.8.3. Reimbursement scenario
7.4.8.4. The Netherlands IVF market, 2018 – 2030 (USD Million)
7.4.9. Switzerland
7.4.9.1. Switzerland estimated fertility rate, 2018 – 2030 (%)
7.4.9.2. Regulatory framework
7.4.9.3. Reimbursement scenario
7.4.9.4. Switzerland IVF market, 2018 – 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific IVF market, 2018 – 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Japan estimated fertility rate, 2018 – 2030 (%)
7.5.2.2. Regulatory framework
7.5.2.3. Reimbursement scenario
7.5.2.4. Japan IVF market, 2018 – 2030 (USD Million)
7.5.3. China
7.5.3.1. China estimated fertility rate, 2018 – 2030 (%)
7.5.3.2. Regulatory framework
7.5.3.3. Reimbursement scenario
7.5.3.4. China IVF market, 2018 – 2030 (USD Million)
7.5.4. India
7.5.4.1. India estimated fertility rate, 2018 – 2030 (%)
7.5.4.2. Regulatory framework
7.5.4.3. Reimbursement scenario
7.5.4.4. India IVF market, 2018 – 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Australia estimated fertility rate, 2018 – 2030 (%)
7.5.5.2. Regulatory framework
7.5.5.3. Reimbursement scenario
7.5.5.4. Australia IVF market, 2018 – 2030 (USD Million)
7.5.6. South Korea
7.5.6.1. South Korea estimated fertility rate, 2018 – 2030 (%)
7.5.6.2. Regulatory framework
7.5.6.3. Reimbursement scenario
7.5.6.4. South Korea IVF market, 2018 – 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America IVF market, 2018 – 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Brazil estimated fertility rate, 2018 – 2030 (%)
7.6.2.2. Regulatory framework
7.6.2.3. Reimbursement scenario
7.6.2.4. Brazil IVF market, 2018 – 2030 (USD Million)
7.6.3. Mexico
7.6.3.1. Mexico estimated fertility rate, 2018 – 2030 (%)
7.6.3.2. Regulatory framework
7.6.3.3. Reimbursement scenario
7.6.3.4. Mexico IVF market, 2018 – 2030 (USD Million)
7.6.4. Argentina
7.6.4.1. Argentina estimated fertility rate, 2018 – 2030 (%)
7.6.4.2. Regulatory framework
7.6.4.3. Reimbursement scenario
7.6.4.4. Argentina IVF market, 2018 – 2030 (USD Million)
7.7. Middle East & Africa
7.7.1. MEA IVF market, 2018 – 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. South Africa estimated fertility rate, 2018 – 2030 (%)
7.7.2.2. Regulatory framework
7.7.2.3. Reimbursement scenario
7.7.2.4. South Africa IVF market, 2018 – 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia estimated fertility rate, 2018 – 2030 (%)
7.7.3.2. Regulatory framework
7.7.3.3. Reimbursement scenario
7.7.3.4. Saudi Arabia IVF market, 2018 – 2030 (USD Million)
7.7.4. UAE
7.7.4.1. UAE estimated fertility rate, 2018 – 2030 (%)
7.7.4.2. Regulatory framework
7.7.4.3. Reimbursement scenario
7.7.4.4. UAE IVF market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Company Profiles
8.1.1. OvaScience, Inc.
8.1.1.1. Overview
8.1.1.2. Financial Performance
8.1.1.3. Service Benchmarking
8.1.1.4. Strategic Initiatives
8.1.2. Vitrolife AB (publ)
8.1.2.1. Overview
8.1.2.2. Financial Performance
8.1.2.3. Service Benchmarking
8.1.2.4. Strategic Initiatives
8.1.3. Emd Serono, Inc.
8.1.3.1. Overview
8.1.3.2. Financial Performance
8.1.3.3. Service Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. FUJIFILM Irvine Scientific
8.1.4.1. Overview
8.1.4.2. Financial Performance
8.1.4.3. Service Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. The Cooper Companies, Inc.
8.1.5.1. Overview
8.1.5.2. Financial Performance
8.1.5.3. Service Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. Thermo Fisher Scientific, Inc.
8.1.6.1. Overview
8.1.6.2. Financial Performance
8.1.6.3. Service Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Bayer AG
8.1.7.1. Overview
8.1.7.2. Financial Performance
8.1.7.3. Service Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. Merck & Co., Inc.
8.1.8.1. Overview
8.1.8.2. Financial Performance
8.1.8.3. Service Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Cook Medical LLC (Cook Group)
8.1.9.1. Overview
8.1.9.2. Financial Performance
8.1.9.3. Service Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Genea Biomedx
8.1.10.1. Overview
8.1.10.2. Financial Performance
8.1.10.3. Service Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Progyny, Inc.
8.1.11.1. Overview
8.1.11.2. Financial Performance
8.1.11.3. Service Benchmarking
8.1.11.4. Strategic Initiatives
8.1.12. Boston IVF
8.1.12.1. Overview
8.1.12.2. Financial Performance
8.1.12.3. Service Benchmarking
8.1.12.4. Strategic Initiatives
8.1.13. Ferring Pharmaceutical B.V.
8.1.13.1. Overview
8.1.13.2. Financial Performance
8.1.13.3. Service Benchmarking
8.1.13.4. Strategic Initiatives
8.2. Company Categorization
8.3. Company Market Position Analysis
8.4. Strategy Mapping
Chapter 9. Recommendations/Key Market Insights

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Clinical trial analysis
Table 4 Comparison between the fresh and frozen donor treatment (U.S.)
Table 5 Canadian law on ART
Table 6 Status of public funding for IVF in Canada
Table 7 Global In-Vitro Fertilization Market, by Region, 2018 - 2030 (USD Million)
Table 8 Global In-Vitro Fertilization Market, by Type, 2018 - 2030 (USD Million)
Table 9 Global In-Vitro Fertilization Market, by End-Use, 2018 - 2030 (USD Million)
Table 10 Global In-Vitro Fertilization Instruments Market, by Region, 2018 - 2030 (USD Million)
Table 11 Global In-Vitro Fertilization Instruments Market, by Type, 2018 - 2030 (USD Million)
Table 12 North America In Vitro Fertilization, by Country, 2018 - 2030 (USD Million)
Table 13 North America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 14 North America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 15 North America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
Table 16 North America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
Table 17 U.S. In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 18 U.S. In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 19 U.S. In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 20 Canada In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 21 Canada In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Canada In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 23 Europe In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
Table 24 Europe In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 25 Europe In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 26 Europe In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
Table 27 Europe In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
Table 28 France In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 29 France In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 30 France In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 31 Germany In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 32 Germany In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 33 Germany In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 34 Italy In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 35 Italy In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 36 Italy In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 37 Spain In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 38 Spain In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Spain In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 40 UK In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 41 UK In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 42 UK In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 43 Belgium In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 44 Belgium In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 45 Belgium In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 46 The Netherlands In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 47 The Netherlands In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 48 Netherlands In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 49 Switzerland In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 50 Switzerland In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Switzerland In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
Table 53 Asia Pacific In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 54 Asia Pacific In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
Table 56 Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
Table 57 Japan In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 58 Japan In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 59 Japan In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 60 China In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 61 China In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 62 China In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 63 India In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 64 India In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 65 India In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 66 Australia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 67 Australia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 68 Australia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 69 South Korea In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 70 South Korea In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 71 South Korea In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 72 Latin America In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
Table 73 Latin America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 74 Latin America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 75 Latin America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
Table 76 Latin America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
Table 77 Brazil In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 78 Brazil In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 79 Brazil In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 80 Mexico In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 81 Mexico In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 82 Mexico In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 83 Argentina In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 84 Argentina In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 85 Argentina In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 86 MEA In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
Table 87 MEA In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 88 MEA In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 89 MEA In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
Table 90 MEA In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
Table 91 South Africa In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 92 South Africa In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 93 South Africa In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
Table 97 UAE In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
Table 98 UAE In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
Table 99 UAE In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 In vitro fertilization market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Supply-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment outlook
Fig. 11 Segment outlook
Fig. 12 Competitive scenario
Fig. 13 In Vitro Fertilization (IVF) parent market outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Market dynamics
Fig. 16 Market driver relevance analysis (Current & future impact)
Fig. 17 Market restraint relevance analysis (Current & future impact)
Fig. 18 In vitro fertilization (IVF) market: Porter’s five forces analysis
Fig. 19 In vitro fertilization (IVF) market: PESTLE analysis
Fig. 20 IVF type market: Segment dashboard
Fig. 21 IVF market by type: Market share analysis, 2022 & 2030
Fig. 22 Global In Vitro Fertilization (IVF) procedures market, by type, 2018 - 2030 (USD Million)
Fig. 23 Fresh nondonor market, 2018 - 2030 (USD Million)
Fig. 24 Frozen nondonor market 2018 - 2030 (USD Million)
Fig. 25 Fresh donor market 2018 - 2030 (USD Million)
Fig. 26 Frozen donor market 2018 - 2030 (USD Million)
Fig. 27 IVF End-Use market: Segment dashboard
Fig. 28 IVF market by End-Use: Market share analysis, 2022 & 2030
Fig. 29 Fertility clinics market, 2018 - 2030 (USD Million)
Fig. 30 Hospitals and other settings market 2018 - 2030 (USD Million)
Fig. 31 IVF instrument market: Segment dashboard
Fig. 32 IVF market by instrument: Market share analysis, 2022 & 2030
Fig. 33 Global In Vitro Fertilization (IVF) procedures market, by instrument, 2018 - 2030 (USD Million)
Fig. 34 Culture media market, 2018 - 2030 (USD Million)
Fig. 35 Disposable devices market, 2018 - 2030 (USD Million)
Fig. 36 Capital equipment market, 2018 - 2030 (USD Million)
Fig. 37 IVF market revenue, by region
Fig. 38 Regional key marketplace takeaway
Fig. 39 Regional key marketplace takeaway
Fig. 40 North America IVF market, 2018 - 2030 (USD Million)
Fig. 41 North America IVF instrument market, 2018 - 2030 (USD Million)
Fig. 42 U.S. estimated fertility rate, 2018 - 2030 (%)
Fig. 43 U.S. IVF market, 2018 - 2030 (USD Million)
Fig. 44 U.S. IVF instrument market, 2018 - 2030 (USD Million)
Fig. 45 Canada estimated fertility rate, 2018 - 2030 (%)
Fig. 46 Canada IVF market, 2018 - 2030 (USD Million)
Fig. 47 Canada IVF instrument market, 2018 - 2030 (USD Million)
Fig. 48 Europe IVF market, 2018 - 2030 (USD Million)
Fig. 49 Europe IVF instrument market, 2018 - 2030 (USD Million)
Fig. 50 France estimated fertility rate, 2018 - 2030 (%)
Fig. 51 France IVF market, 2018 - 2030 (USD Million)
Fig. 52 France IVF instrument market, 2018 - 2030 (USD Million)
Fig. 53 Germany estimated fertility rate, 2018 - 2030 (%)
Fig. 54 Germany IVF market, 2018 - 2030 (USD Million)
Fig. 55 Germany IVF instrument market, 2018 - 2030 (USD Million)
Fig. 56 Italy estimated fertility rate, 2018 - 2030 (%)
Fig. 57 Italy IVF market, 2018 - 2030 (USD Million)
Fig. 58 Italy IVF instrument market, 2018 - 2030 (USD Million)
Fig. 59 Spain estimated fertility rate, 2018 - 2030 (%)
Fig. 60 Spain IVF market, 2018 - 2030 (USD Million)
Fig. 61 Spain IVF instrument market, 2018 - 2030 (USD Million)
Fig. 62 UK estimated fertility rate, 2018 - 2030 (%)
Fig. 63 UK IVF market, 2018 - 2030 (USD Million)
Fig. 64 UK IVF instrument market, 2018 - 2030 (USD Million)
Fig. 65 Belgium estimated fertility rate, 2018 - 2030 (%)
Fig. 66 Belgium IVF market, 2018 - 2030 (USD Million)
Fig. 67 Belgium IVF instrument market, 2018 - 2030 (USD Million)
Fig. 68 The Netherlands estimated fertility rate, 2018 - 2030 (%)
Fig. 69 The Netherlands IVF market, 2018 - 2030 (USD Million)
Fig. 70 The Netherlands IVF instrument market, 2018 - 2030 (USD Million)
Fig. 71 Switzerland estimated fertility rate, 2018 - 2030 (%)
Fig. 72 Switzerland IVF market, 2018 - 2030 (USD Million)
Fig. 73 Switzerland IVF instrument market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific IVF market, 2018 - 2030 (USD Million)
Fig. 75 Asia Pacific IVF instrument market, 2018 - 2030 (USD Million)
Fig. 76 Japan estimated fertility rate, 2018 - 2030 (%)
Fig. 77 Japan IVF market, 2018 - 2030 (USD Million)
Fig. 78 Japan IVF instrument market, 2018 - 2030 (USD Million)
Fig. 79 China estimated fertility rate, 2018 - 2030 (%)
Fig. 80 China IVF market, 2018 - 2030 (USD Million)
Fig. 81 China IVF instrument market, 2018 - 2030 (USD Million)
Fig. 82 India. estimated fertility rate, 2018 - 2030 (%)
Fig. 83 India IVF market, 2018 - 2030 (USD Million)
Fig. 84 India IVF instrument market, 2018 - 2030 (USD Million)
Fig. 85 Australia estimated fertility rate, 2018 - 2030 (%)
Fig. 86 Australia IVF market, 2018 - 2030 (USD Million)
Fig. 87 Australia IVF instrument market, 2018 - 2030 (USD Million)
Fig. 88 South Korea estimated fertility rate, 2018 - 2030 (%)
Fig. 89 South Korea IVF market, 2018 - 2030 (USD Million)
Fig. 90 South Korea IVF instrument market, 2018 - 2030 (USD Million)
Fig. 91 Latin America IVF market, 2018 - 2030 (USD million)
Fig. 92 Latin America IVF instrument market, 2018 - 2030 (USD million)
Fig. 93 Brazil estimated fertility rate, 2018 - 2030 (%)
Fig. 94 Brazil IVF market, 2018 - 2030 (USD Million)
Fig. 95 Brazil IVF instrument market, 2018 - 2030 (USD Million)
Fig. 96 Mexico estimated fertility rate, 2018 - 2030 (%)
Fig. 97 Mexico IVF market, 2018 - 2030 (USD Million)
Fig. 98 Mexico IVF instrument market, 2018 - 2030 (USD Million)
Fig. 99 Argentina estimated fertility rate, 2018 - 2030 (%)
Fig. 100 Argentina IVF market, 2018 - 2030 (USD Million)
Fig. 101 Argentina IVF instrument market, 2018 - 2030 (USD Million)
Fig. 102 MEA IVF market, 2018 - 2030 (USD Million)
Fig. 103 MEA IVF instrument market, 2018 - 2030 (USD Million)
Fig. 104 South Africa estimated fertility rate, 2018 - 2030 (%)
Fig. 105 South Africa IVF market, 2018 - 2030 (USD million)
Fig. 106 South Africa IVF instrument market, 2018 - 2030 (USD Million)
Fig. 107 Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
Fig. 108 Saudi Arabia IVF market, 2018 - 2030 (USD million)
Fig. 109 Saudi Arabia IVF instrument market, 2018 - 2030 (USD Million)
Fig. 110 UAE estimated fertility rate, 2018 - 2030 (%)
Fig. 111 UAE IVF market, 2018 - 2030 (USD million)
Fig. 112 UAE IVF instrument market, 2018 - 2030 (USD Million)
Fig. 113 Company categorization
Fig. 114 Company market position analysis
Fig. 115 Strategy mapping

★調査レポート[世界の体外受精市場2023-2030：機器別（使い捨て機器、培養液）、処置種類別（新鮮ノンドナー、凍結ノンドナー）、エンドユーザー別] (コード：GRV23NOV147)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の体外受精市場2023-2030：機器別（使い捨て機器、培養液）、処置種類別（新鮮ノンドナー、凍結ノンドナー）、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の体外受精（IVF）市場2024-2030：機器別（使い捨て機器、培養培地）、処置種類別（新鮮ノンドナー、凍結ノンドナー）、エンドユーザー別、地域別
  • 世界の美容医療市場2023-2030：処置種類別（非侵襲的、侵襲的）、地域別（北米、アジア太平洋、ヨーロッパ）
  • 世界の細胞治療技術市場（～2028年）：製品別（培地、血清＆試薬、細胞培養容器、使い捨て機器）、プロセス別（細胞処理、保存）、細胞種類別（T細胞、幹細胞）、エンドユーザー別（バイオ医薬品、CRO、CMO）、地域別
  • 世界の中央研究所市場2024-2030：サービス別（遺伝子サービス、バイオマーカーサービス）、エンドユーザー別（製薬企業、バイオテクノロジー企業）、地域別
  • 世界の解毒薬市場2024-2030：種類別（化学的解毒剤、物理的解毒剤、薬理学的解毒剤）、投与経路別、流通チャネル別、エンドユーザー別、地域別
  • 世界の神経バイオマーカー市場2024-2030：用途別（アルツハイマー病、パーキンソン病、多発性硬化症、自閉症）、種類別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆